海利生物(603718.SH)擬收購楊凌金海40%股權並向其增資8000萬元
格隆匯3月16日丨海利生物(603718.SH)公佈,2021年3月15日,公司召開第三屆董事會第二十三次會議,審議通過了《關於公司收購控股子公司少數股東權益並增資暨關聯交易的議案》,
公司擬收購BIOGéNESIS BAGó S.A.,(以下簡稱BBA)和BIOGéNESIS BAGó URUGUAY S.A.,(以下簡稱BBU,BBA和BBU合稱為BB公司或賣方)合計持有的公司控股子公司楊凌金海生物技術有限公司(以下簡稱楊凌金海或目標公司)40%的股權,收購價格為人民幣5600萬元。
在收購完成後,為進一步緩解楊凌金海的資金壓力,促進其進一步發展,公司擬增資8000萬元,其中5500萬元(截至目前公司與楊凌金海之間累計借款餘額即為5500萬元)為債轉股的方式出資,2500萬元為現金直接出資。(以下簡稱本次增資,上述收購及增資事項統稱為本次交易)。
本次交易完成後,楊凌金海由中外合資企業變更為內資企業,公司持有楊凌金海的股權比例由55%變更為76.07%,楊凌金海仍為公司的控股子公司。潤瓴投資與公司同比例增資6,000萬元,獲得目標公司21.43%的股權。潤苗投資為目標公司持股5%的股東,不參與本次增資,故本次交易完成後,持股比例被稀釋至2.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.